Ana María Herrero-Beites

Effect of urate‐lowering therapy on the velocity of size reduction of tophi in chronic gout

Fernando Pérez-Ruiz, M Calabozo, José Ignacio Pijoán et al. · Arthritis Care & Research · 2002 · 451 citations

Pharmacy, Pharmacotherapy, Bioavailability +13

Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout

Fernando Pérez-Ruiz, A. Alonso-Ruiz, M Calabozo et al. · Annals of the Rheumatic Diseases · 1998 · 256 citations · Full text

Pharmacy, Pharmacotherapy, Bioavailability +12

Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output

Fernando Pérez-Ruiz, M Calabozo, Gorka García Erauskin et al. · Arthritis Care & Research · 2002 · 251 citations

Pharmacy, Nephrology, Pharmacotherapy +14

Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout

Fernando Pérez-Ruiz, Lorea Martínez‐Indart, Loreto Carmona et al. · Annals of the Rheumatic Diseases · 2013 · 214 citations

Medicine, Cardiology, Clinical Epidemiology +12

Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients

Fernando Pérez-Ruiz, Maria Angeles Aniel-Quiroga, Ana María Herrero-Beites et al. · Rheumatology International · 2015 · 107 citations

Medicine, Endocrinology, Nephrology +10